FDA NDC Directory · JSON-LD · Markdown

TAZVERIK

NDC 72607-100 · HUMAN PRESCRIPTION DRUG · TABLET, FILM COATED

Generic nametazemetostat
Labeler / ManufacturerEpizyme, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA211723
Dosage form / routeTABLET, FILM COATED · ORAL
Active ingredientsTAZEMETOSTAT HYDROBROMIDE (200 mg/1)
Marketing started20200123
Marketing ended20290430
Package count1

External sources

Source: openFDA. Public-domain (CC0).